​

Moleculin Biotech Ownership | Who Owns Moleculin Biotech?

OverviewForecastRevenueFinancialsChartTranscripts

Moleculin Biotech Ownership Summary

Moleculin Biotech is owned by 3.69% institutional investors, 2.24% insiders, and 94.07% retail investors. Vanguard group is the largest institutional shareholder, holding 1.55% of MBRX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 0.97% of its assets in Moleculin Biotech shares.

MBRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMoleculin Biotech3.69%2.24%94.07%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group239.92K1.55%$127.16K
Geode capital management208.21K1.34%$110.35K
Hrt financial lp115.19K0.74%$61.00K
Lpl financial58.08K0.37%$30.78K
Ieq capital36.36K0.23%$19.27K
Wealth dimensions group20.00K0.13%$10.60K
Rockefeller capital management14.51K0.09%$7.69K
Cambridge investment research advisors12.78K0.08%$7.00K
Goldman sachs group12.75K0.08%$6.76K
Blackrock funding, inc. /de12.38K0.08%$6.56K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Wealth dimensions group20.00K0.00%$10.60K
Ethos financial group10.03K0.00%$5.32K
Moors & cabot10.00K0.00%$5.30K
Newbridge financial services group2.87K0.00%$1.52K
Hrt financial lp115.19K0.00%$61.00K
Tower research capital llc (trc)8.38K0.00%$4.44K
Ieq capital36.36K0.00%$19.27K
Rockefeller capital management14.51K-$7.69K
Atlantic union bankshares---
Cva family office34.00-$18.00

Top Buyers

HolderShares% AssetsChange
Vanguard group239.92K-208.98K
Geode capital management208.21K-180.68K
Hrt financial lp115.19K0.00%115.19K
Ieq capital36.36K0.00%36.36K
Wealth dimensions group20.00K0.00%20.00K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.25M
Citigroup---85.28K
Xtx topco---74.22K
Cetera investment advisers---70.00K
Virtu financial---59.28K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp115.19K0.00%115.19K$61.00K
Ieq capital36.36K0.00%36.36K$19.27K
Wealth dimensions group20.00K0.00%20.00K$10.60K
Rockefeller capital management14.51K-14.51K$7.69K
Goldman sachs group12.75K-12.75K$6.76K

Sold Out

HolderChange
Atlantic union bankshares-379.00
Stone house investment management-3.30K
Verus capital partners-43.00K
Virtu financial-59.28K
Cetera investment advisers-70.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202512-45.45%573,00132.44%347.53%5-58.33%--
Jun 30, 2025224.76%432,658-70.73%21.11%1318.18%--100.00%
Mar 31, 20252110.53%1,478,032218.10%158.69%1122.22%2-60.00%
Dec 31, 20241911.76%464,6500.89%138.78%912.50%566.67%
Sep 30, 20241713.33%460,56346.81%128.15%8-20.00%350.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF40.47K0.97%-13.02K
Vanguard Total Stock Mkt Idx Inv16.86K0.56%-23.61K
Vanguard Institutional Extnd Mkt Idx Tr87.49K0.29%57.17K
Fidelity Extended Market Index66.55K0.22%48.06K
Fidelity Series Total Market Index20.42K0.07%14.57K
Spartan Total Market Index Pool G8.49K0.03%7.37K
SSgA U.S. Extended Market Index Class I11.70K0.03%-
NT Ext Eq Mkt Indx Fd DC Lend T3414.000.01%414.00
NT Ext Eq Mkt Indx Fd DC Lend T4414.000.01%414.00
Schwab Total Stock Market Index366.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 23, 2025Foster Jonathan P. Chief Financial OfficerBuy$100.00K
Jun 23, 2025Foster Jonathan P. Chief Financial OfficerSell$300.00K
Jun 23, 2025KLEMP WALTER V CEO and PresidentSell$750.00K
Jun 23, 2025KLEMP WALTER V CEO and PresidentBuy$250.00K
Dec 26, 2023Foster Jonathan P. Chief Financial OfficerBuy$20.00K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q24-
2024 Q4--
2024 Q3--
2024 Q2--

MBRX Ownership FAQ

Who Owns Moleculin Biotech?

Moleculin Biotech shareholders are primarily institutional investors at 3.69%, followed by 2.24% insiders and 94.07% retail investors. The average institutional ownership in Moleculin Biotech's industry, Biotech Stocks , is 45.22%, which Moleculin Biotech falls below.

Who owns the most shares of Moleculin Biotech?

Moleculin Biotech’s largest shareholders are Vanguard group (239.92K shares, 1.55%), Geode capital management (208.21K shares, 1.34%), and Hrt financial lp (115.19K shares, 0.74%). Together, they hold 3.63% of Moleculin Biotech’s total shares outstanding.

Does Blackrock own Moleculin Biotech?

BlackRock is not among the top 10 institutional shareholders of Moleculin Biotech.

Who is Moleculin Biotech’s biggest shareholder by percentage of total assets invested?

Wealth dimensions group is Moleculin Biotech’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 20K Moleculin Biotech shares, valued at 10.6K$.

Who is the top mutual fund holder of Moleculin Biotech shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Moleculin Biotech shares, with 0.97% of its total shares outstanding invested in 40.47K Moleculin Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools